Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Amphivena Therapeutics

Amphivena Therapeutics

Amphivena Therapeutics is a bi-functional antibody therapy founded in 2012.

OverviewStructured DataIssuesContributorsActivity
Is a
Company
Company
Organization
Organization
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
info@amphivena.com
Founded Date
2012
Industry
Biopharmaceutical
Biopharmaceutical
Immunotherapy
Immunotherapy
Biomedical engineering
Biomedical engineering
Engineering
Engineering
Investors
‌
Franklin M. Berger
Korys
Korys
Kaitai Capital
Kaitai Capital
Industrial Investors
Industrial Investors
Clough Capital Partners
Clough Capital Partners
Tekla Capital Management
Tekla Capital Management
‌
StoneFund
MPM Capital
MPM Capital
‌
Nawton Limited
Qi Ming Venture Partners
Qi Ming Venture Partners
•••
Latest Funding Round Date
September 2019
Latest Funding Type
Series C
Series C
LinkedIn URL
@company/amphivena-therapeutics-inc-
Location
San Francisco
San Francisco
Patents Assigned (Count)
2
Phone Number
+16504993178
Total Funding Amount (USD)
76,000,000
Official Website
amphivena.com

Find more companies like Amphivena Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo